Compare Centrus Energy Corp (LEU) vs Neurocrine Biosciences Inc (NBIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Centrus Energy Corp vs Neurocrine Biosciences Inc — how do they compare? Centrus Energy Corp trades at $190 (market cap $3.77B), while Neurocrine Biosciences Inc trades at $156.86 (market cap $16.46B). The key difference: Neurocrine Biosciences Inc is far larger — about 4.4× Centrus Energy Corp's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Centrus Energy Corp nearer its low. Which is the better fit depends on your goals.
| LEU | NBIX | |
|---|---|---|
Market Cap | $3.77B | $16.46B |
Sector | Energy | Health |
52-Week High | $436.00 | $185.50 |
52-Week Low | $146.61 | $123.10 |
Enterprise Value | $3.08B | $16.48B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Centrus Energy Corp
Centrus Energy is a leading supplier of nuclear fuel and services for the global power industry. It specializes in supplying low-enriched uranium and developing next-generation fuels for advanced nuclear reactors.
Read more on LEU →About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →
